Yale Cancer Center

VA and IBM Watson Health Extend Partnership to Support Veterans With Cancer

Retrieved on: 
Thursday, July 19, 2018

First announced two years ago as part of the National Cancer Moonshot Initiative , VA oncologists have now used IBM Watson for Genomics technology to support precision oncology care for more than 2,700 Veterans with cancer.

Key Points: 
  • First announced two years ago as part of the National Cancer Moonshot Initiative , VA oncologists have now used IBM Watson for Genomics technology to support precision oncology care for more than 2,700 Veterans with cancer.
  • By knowing the cancer genome, oncologists and patients are able to choose therapies that specifically target the patient's cancer.
  • The partnership extension with IBM will enable VA oncologists to continue using Watson for Genomics through at least June 2019.
  • VA treats 3.5 percent of the nation's cancer patients the largest group of cancer patients within any one health-care group.

National Comprehensive Cancer Network Announces New Chief Medical Officer

Retrieved on: 
Thursday, May 17, 2018

FORT WASHINGTON, Pa., May 17, 2018 /PRNewswire/ --The National Comprehensive Cancer Network ( NCCN ) has named Wui-Jin Koh, MD, as Senior Vice President, Chief Medical Officer; a newly-created position for the nonprofit alliance of top U.S. cancer centers.

Key Points: 
  • FORT WASHINGTON, Pa., May 17, 2018 /PRNewswire/ --The National Comprehensive Cancer Network ( NCCN ) has named Wui-Jin Koh, MD, as Senior Vice President, Chief Medical Officer; a newly-created position for the nonprofit alliance of top U.S. cancer centers.
  • Dr. Koh also served as a member of the pancreatic cancer panel for seven years, and currently sits on the editorial board of JNCCN Journal of the National Comprehensive Cancer Network .
  • The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 27 leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.
  • The NCCN Member Institutions are: Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Comprehensive Cancer Center, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Rogel Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; University of Wisconsin Carbone Cancer Center, Madison, WI; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.
    Clinicians, visit NCCN.org .